Baillie Gifford Global Discovery Fund B Accumulation

Baillie Gifford Global Discovery Fund B Accumulation
Baillie Gifford & Co Limited.
Open Ended Investment Company
0.79 %
Risk Rating
3 Year Sharpe
3 Year Alpha
0 %
S&P Global Small TR USD
The objective is to produce attractive returns over the long term by investing globally in transferable securities of companies that the ACD considers offer excellent future growth prospects. The Sub-fund may also invest in money market instruments, cash and near cash. In addition, the Sub-fund also has the ability to invest up to (but no more than) 10% in value of the Sub-fund in each of the following: collective investment schemes and deposits.
Holding %
Ocado Group PLC 5.26 %
LendingTree Inc 4.47 %
Alnylam Pharmaceuticals Inc 3.78 %
Chegg Inc 3.55 %
MarketAxess Holdings Inc 3.28 %
NovoCure Ltd 2.80 %
Exact Sciences Corp 2.54 %
Wayfair Inc Class A 2.53 %
Yext Inc 2.50 %
Zillow Group Inc C 2.43 %
Region %
United States 66.13 %
United Kingdom 13.53 %
Sector %
Healthcare 34.92 %
Technology 29.85 %
Consumer Cyclical 9.81 %
Financial Services 9.54 %
Consumer Defensive 9.12 %
Baillie Gifford & Co Limited.
EH1 3AN, Edinburgh, United Kingdom
Legal Structure
Open Ended Investment Company


Luke Ward
Joined 01/01/2018

Luke graduated MEng (Hons) in Mechanical Engineering from the University of Edinburgh in 2012. Luke joined Baillie Gifford in 2012 and is an Investment Manager in the Global Discovery Team. Luke is also a Deputy Manager.

Svetlana Viteva
Joined 01/01/2018

Svetlana graduated BA in Economics and BA in Business Administration from the American University in Bulgaria in 2008, MSc in Investment Analysis from Stirling University in 2009 and PhD in Accounting and Finance from Stirling University in 2012. Svetlana joined Baillie Gifford in 2012 and is an Investment Manager in the Global Discovery Team. Svetlana is also a Deputy Manager. She is a CFA Charterholder.

Douglas Brodie
Joined 05/01/2011

Douglas graduated BSc in Molecular Biology & Biochemistry from Durham University in 1997 and with a DPhil in Molecular Immunology from the University of Oxford in 2001. He joined Baillie Gifford in 2001 and is Head of the Global Discovery Team. Douglas became a Partner in 2015 is a CFA Charterholder.

Data provided by Morningstar.

The Content is only for your general information and use and is not intended to address your particular requirements. The Content does not constitute any form of advice, recommendation or arrangement by Money Observer and is not intended to be relied upon by you in making (or refraining from making) any specific investment or other decisions. Appropriate independent advice should be obtained before making any such decision.

This information is sourced from our partner Morningstar. We believe the data to be correct however you should take care in using any information.

You should be aware that prices may fall as well as rise and that the income derived can go down as well as up. When buying or selling any investment that fluctuates in price or value you may get back less than you invested. Past performance is not necessarily a guide to future performance.